JP2006001917A - Method for producing coenzyme q10 - Google Patents
Method for producing coenzyme q10 Download PDFInfo
- Publication number
- JP2006001917A JP2006001917A JP2004207931A JP2004207931A JP2006001917A JP 2006001917 A JP2006001917 A JP 2006001917A JP 2004207931 A JP2004207931 A JP 2004207931A JP 2004207931 A JP2004207931 A JP 2004207931A JP 2006001917 A JP2006001917 A JP 2006001917A
- Authority
- JP
- Japan
- Prior art keywords
- coenzyme
- water
- cyclodextrin
- improved
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は水溶性、乳化エマルジョン化性大なる補酵素、コエンザイムQ10の製造法に関するものである。 The present invention relates to a method for producing coenzyme Q10, a coenzyme having a high water solubility and emulsification ability.
従来、水等に不溶性の補酵素、コエンザイムQ10はそのまま錠剤、カプセル化し、製品化したので胃腸内で吸収も悪く、胃腸障害もあり、薬効も低下、光を受けたり酸化して変質しやすく不安定な性質をもっている。
この欠点を除くため、油等に溶かしソフトカプセル化等して製品加工し、かなり胃腸よりの吸収も改善され、品質もやゝ安定化したが、まだ吸収も不十分で、光に対し不安定、又酸化し易い成分なので、未完成の品質のまま経過し使用されて来た。Conventionally, coenzyme Q10, which is insoluble in water, etc., is directly tableted, encapsulated, and commercialized, so it is poorly absorbed in the gastrointestinal tract, has gastrointestinal disorders, has a reduced medicinal effect, and is easily damaged by light and oxidized. It has a stable nature.
In order to eliminate this defect, it was dissolved in oil etc. and processed into a soft capsule, etc., and the gastrointestinal absorption was considerably improved, the quality was stabilized, but the absorption was still insufficient and unstable to light. In addition, since it is a component that easily oxidizes, it has been used in an unfinished quality.
従来法では次の様な問題点があった。
コエンザイムQ10を加工しないで不溶性のまま錠剤化したり、せいぜい油類等に溶解して軟カプセル化する方法がとられた。
しかし、この程度の加工法では幾分胃腸からの吸収も改善され、コエンザイム成分の光に弱く、酸化され易い不安定性も少しは改善されたが、まだまだ不完全であった。The conventional method has the following problems.
Coenzyme Q10 was tableted without being processed without being processed, or at most it was dissolved in oils to form a soft capsule.
However, this level of processing improved the gastrointestinal absorption somewhat and the coenzyme component, which was weak against light and easily oxidised instability, was still incomplete, but still incomplete.
シクロデキストリンの通常0.3〜3倍重量の水を加え、よく混合しねった水和物中にコエンザイムQ10を均一に混和して行き、一定時間よく混和攪拌(通常30分〜数時間程度)、シクロデキストリン分子空洞内にコエンザイムQ10分子を包接加工させる。
例えばシクロデキストリン100グラムに50mlの水を加え、よく泥状にねって混和した水和混合物にコエンザイムQ10、30グラムを徐々に加え攪拌混合すると、コエンザイムQ10分子をシクロデキストリン分子空洞内に包接させることができ、水に対する乳化エマルジョン化し易い性質に改質、又、光や酸化に対し安定な性質に加工できる。Add usually 0.3 to 3 times the weight of cyclodextrin water, and mix Coenzyme Q10 uniformly into the well-mixed hydrate and mix well for a certain time (usually about 30 minutes to several hours) Coenzyme Q10 molecules are included in the cyclodextrin molecular cavity.
For example, when 50 ml of water is added to 100 g of cyclodextrin, 30 g of coenzyme Q10 is gradually added to the hydrated mixture mixed well in a muddy state, and stirred and mixed, the coenzyme Q10 molecule is included in the cyclodextrin molecular cavity. It can be modified to easily emulsify with water, and can be processed to be stable to light and oxidation.
従来のコエンザイムQ10は水等に対し不溶性、疎水性であるし、光に照射され速かに分解され易く、又酸化され易い、不安定な性質を持っているが本発明にかかる製造法により、6個から10個のD−グルコピラノース基がα(1.4)グルコシド結合により環状結合したオリゴマーであり重合度によりα−(6)、β−(7)、δ−(8)シクロデキストリンが主として用いられ、このシクロデキストリンを水と混和し、この水和(水との混合)物にコエンザイムQ10を混和、なるべく強力にねり合せ攪拌することにより、シクロデキストリンは分子内に各種の有機化合物(ゲスト分子)を包接できる空洞をもつ単分子的ホスト分子として、この混合時間中にゲスト分子であるコエンザイムQ10分子を包接させ安定化せしめるのである。 Conventional coenzyme Q10 is insoluble and hydrophobic in water, etc., and is easily decomposed when irradiated with light and easily oxidized, but has an unstable property. It is an oligomer in which 6 to 10 D-glucopyranose groups are cyclically linked by α (1.4) glucoside bond, and α- (6), β- (7), δ- (8) cyclodextrin is formed depending on the degree of polymerization. Mainly used, this cyclodextrin is mixed with water, and coenzyme Q10 is mixed with this hydrated (mixed with water) mixture. As a unimolecular host molecule having a cavity that can include a guest molecule), the guest molecule Coenzyme Q10 molecule is included and stabilized during this mixing time.
例をあげて本製造法を説明する。
シクロデキストリンにはα−CD、β−CD、δ−CD等の種類があるが、コエンザイムQ10分子の加工にはδ−CDが適している。
シクロデキストリン100gに50mlの水を加え、乳鉢等でよくねり、泥状の水和物を作り、これにコエンザイムQ10末30gを徐々に添加、よく均等に混和し、30分〜数時間位擂潰機、練合機、ホモジナイザー等で十分に攪拌、れん合させ包接加工を完成させる。
一般に時間と共に、やや粘度が上昇しペースト状になると含水包接体が生成されたものとみなされる。そして必要に応じ、これを乾燥後、適当な溶媒で洗浄すれば安定した包接体が得られる。The production method will be described with an example.
Cyclodextrins include α-CD, β-CD, and δ-CD, and δ-CD is suitable for processing coenzyme Q10 molecules.
Add 50 ml of water to 100 g of cyclodextrin, knead well in a mortar, etc. to make a mud hydrate, gradually add 30 g of coenzyme Q10 powder, mix well, and crush for about 30 minutes to several hours. Thoroughly mix and stir with a machine, kneader, homogenizer, etc. to complete the inclusion process.
In general, it is considered that a hydrous clathrate has been produced when the viscosity slightly increases with time and becomes a paste. If necessary, the clathrate can be obtained by drying and washing with an appropriate solvent.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004207931A JP2006001917A (en) | 2004-06-17 | 2004-06-17 | Method for producing coenzyme q10 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004207931A JP2006001917A (en) | 2004-06-17 | 2004-06-17 | Method for producing coenzyme q10 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006001917A true JP2006001917A (en) | 2006-01-05 |
Family
ID=35770607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004207931A Pending JP2006001917A (en) | 2004-06-17 | 2004-06-17 | Method for producing coenzyme q10 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006001917A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008007415A1 (en) * | 2006-07-10 | 2008-01-17 | Kanehide Bio Co., Ltd. | Inclusion coenzyme q10 and method of producing inclusion coenzyme q10 |
JP2008291150A (en) * | 2007-05-25 | 2008-12-04 | Cyclochem:Kk | Astaxanthin-cyclodextrin inclusion compound |
CN101420943B (en) * | 2006-04-11 | 2012-09-26 | 三荣源有限公司 | Chewing composition containing coenzyme q10 |
-
2004
- 2004-06-17 JP JP2004207931A patent/JP2006001917A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101420943B (en) * | 2006-04-11 | 2012-09-26 | 三荣源有限公司 | Chewing composition containing coenzyme q10 |
WO2008007415A1 (en) * | 2006-07-10 | 2008-01-17 | Kanehide Bio Co., Ltd. | Inclusion coenzyme q10 and method of producing inclusion coenzyme q10 |
JPWO2008007415A1 (en) * | 2006-07-10 | 2009-12-10 | 金秀バイオ株式会社 | Inclusion Coenzyme Q10 and Method for Producing Inclusion Coenzyme Q10 |
JP2008291150A (en) * | 2007-05-25 | 2008-12-04 | Cyclochem:Kk | Astaxanthin-cyclodextrin inclusion compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Modified ammonium persulfate oxidations for efficient preparation of carboxylated cellulose nanocrystals | |
EP2167568B1 (en) | Production of cellulose nanoparticles | |
PT912633E (en) | ADDITIVATION OF CELLULOSE NANOFIBRILLAS WITH CARBOXILATE CELLULOSE WITH LOW DEGREE OF REPLACEMENT | |
CN1361806A (en) | Pullulan film compositions | |
Xu et al. | Controlled release of lysozyme based core/shells structured alginate beads with CaCO3 microparticles using Pickering emulsion template and in situ gelation | |
JP5317632B2 (en) | Preparation method of chitosan nanoparticles in aqueous phase | |
JP5629327B2 (en) | Method for solubilizing poorly soluble / insoluble active substances by formation of oligomer complexes | |
CN1312296A (en) | Use of G-blocked polyose | |
KR101342486B1 (en) | New Soft Gelatin Capsules | |
JP2006001917A (en) | Method for producing coenzyme q10 | |
JP2023099144A (en) | β-1,3-1,6-GLUCAN POWDER, GLUCAN-CONTAINING COMPOSITION, METHOD FOR PRODUCING β-1,3-1,6-GLUCAN POWDER, INCLUSION COMPLEX, METHOD FOR PRODUCING INCLUSION COMPLEX, AND METHOD FOR RECOVERING GUEST MOLECULE | |
JPH0753396A (en) | Cyclodextrin clathrate of taxol, its production method and use | |
JP2010116358A (en) | Dispersion of c60-containing nanoparticle and method for producing the same | |
FR2808705A1 (en) | Method for preparing a hydrocolloid powder composition for use as e.g. thickening or gelling agent comprises contacting a crosslinking agent with an absorbent powder, mixing with a hydrocolloid powder and heating | |
JP2016183120A (en) | INCLUSION METHOD OF POORLY WATER SOLUBLE SUBSTANCE INTO β-1,3-1,6-GLUCAN AND INCLUSION AGENT FOR USE IN METHOD THEREOF | |
JP4560647B2 (en) | Method for producing soluble starch | |
JP2001186862A (en) | Powdery aureobasidium culture liquid composition, method for producing the same and powder mixture using the composition | |
CN1167713C (en) | Prepn. of water soluble chitosan with controllable molecular weight | |
JPWO2008007415A1 (en) | Inclusion Coenzyme Q10 and Method for Producing Inclusion Coenzyme Q10 | |
JPS643467B2 (en) | ||
JP2008214588A (en) | Inclusion compound of vinylidene fluoride oligomer | |
JPH04316597A (en) | Ferulic acid ester of triterpene alcohol-branched cyclodextrin molecular compound | |
JPH0357085B2 (en) | ||
JP2009269829A (en) | Squalene/cyclodextrin clathrate pseudorotaxane | |
WO2011080422A1 (en) | Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof |